Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial
- 1 June 2000
- Vol. 18 (24) , 2686-2692
- https://doi.org/10.1016/s0264-410x(00)00050-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6Epidemiology and Infection, 1999
- Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate VaccineThe Journal of Infectious Diseases, 1997
- Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom InfantsThe Journal of Infectious Diseases, 1996
- Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trialPublished by American Medical Association (AMA) ,1996
- Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among childrenThe Journal of Pediatrics, 1996
- A Trial Of A Group A Plus Group C Meningococcal Polysaccharide-ProteinThe Journal of Infectious Diseases, 1995
- The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidisJAMA, 1995
- Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccineJournal of Infection, 1988
- Duration of Antibody Responses after Vaccination with Group C Neisseria meningitidis PolysaccharideThe Journal of Infectious Diseases, 1975
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969